Mera Pharmaceuticals, Inc.
MRPI
$0.00
$0.000.00%
OTC PK
| 10/31/2011 | 07/31/2011 | 04/30/2011 | 01/31/2011 | 10/31/2010 | |
|---|---|---|---|---|---|
| Net Income | -102.20K | -15.80K | -35.10K | -34.70K | -394.60K |
| Total Depreciation and Amortization | 2.10K | 2.10K | 1.30K | 2.80K | 5.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 600.00 | -- | -- | -- | 314.40K |
| Change in Net Operating Assets | 27.20K | 16.40K | 30.40K | 32.90K | -64.80K |
| Cash from Operations | -72.20K | 2.70K | -3.40K | 1.00K | -139.20K |
| Capital Expenditure | 0.00 | 0.00 | -2.30K | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 0.00 | -2.30K | -- | 0.00 |
| Total Debt Issued | 72.50K | -- | -- | -- | 144.30K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 72.50K | -- | -- | -- | 144.30K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 300.00 | 2.70K | -5.70K | 1.00K | 5.10K |